Myriad Genetics Inc at Morgan Stanley Healthcare Conference Transcript
Right. I'll go ahead and read the disclosure. Please note that all important disclosures, including personal holding disclosures and Morgan Stanley disclosures, appear on the Morgan Stanley public website at www.morganstanley.com/researchdisclosures or at the registration desk. My name is Anthony Yu. I am Vice President in Morgan Stanley's Healthcare Investment Banking team. I'm joined up here on stage with Mark Capone, CEO of Myriad Genetics. I will just give him a few minutes to give a brief introduction about himself and the company. I'm sure everybody is aware of it.
All right. Thank you, Anthony, and good morning, and thanks to Morgan Stanley for hosting another outstanding conference. For those who don't know, Myriad was founded about 27 years ago as the pioneer in precision medicine. Precision medicine has dual aims, that
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |